{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T07:12:09Z","timestamp":1795158729780,"version":"4.10.3"},"reference-count":99,"publisher":"Hindawi Limited","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2130,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1111\/j.1529-8019.2009.01272.x","type":"journal-article","created":{"date-parts":[[2009,11,4]],"date-time":"2009-11-04T15:35:26Z","timestamp":1257348926000},"page":"491-502","source":"Crossref","is-referenced-by-count":228,"title":["Cutaneous and mucocutaneous leishmaniasis"],"prefix":"10.1155","volume":"22","author":[{"given":"Consuelo V.","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah","family":"Craft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","reference":[{"issue":"9496","key":"10.1111\/j.1529-8019.2009.01272.x-BIB1","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01272.x-BIB2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.cimid.2004.03.004","article-title":"Leishmaniasis: current situation and new perspectives","volume":"27","author":"Desjeux","year":"2004","journal-title":"Comp Immunol Microbiol Infect Dis"},{"issue":"9185","key":"10.1111\/j.1529-8019.2009.01272.x-BIB3","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S0140-6736(98)10178-2","article-title":"Leishmaniasis","volume":"354","author":"Herwaldt","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB4","first-page":"407","article-title":"Diagnosis & management of Leishmania\/HIV co-infection","volume":"121","author":"Sinha","year":"2005","journal-title":"Indian J Med Res"},{"key":"10.1111\/j.1529-8019.2009.01272.x-BIB5","volume-title":"WHO fact sheet","author":"World Health Organization","year":"2000"},{"key":"10.1111\/j.1529-8019.2009.01272.x-BIB6","unstructured":"6.\u2002US Department of Defense DHCC. Leishmaniasis: information for clinicians. 2004: 1-4. http:\/\/www.pdhealth.mil\/downloads\/Leishmaniasis_Clinicians_06212004_Uploaded_05112005.pdf. Accessed May 21, 2009."},{"issue":"7385","key":"10.1111\/j.1529-8019.2009.01272.x-BIB7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/bmj.326.7385.377","article-title":"Leishmaniasis: new approaches to disease control","volume":"326","author":"Davies","year":"2003","journal-title":"BMJ"},{"key":"10.1111\/j.1529-8019.2009.01272.x-BIB8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0065-2776(08)60912-8","article-title":"The host response to Leishmania infection","volume":"74","author":"Solbach","year":"2000","journal-title":"Adv Immunol"},{"issue":"14","key":"10.1111\/j.1529-8019.2009.01272.x-BIB9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3109\/08830189809084491","article-title":"Cytokines in parasitic diseases: the example of cutaneous leishmaniasis","volume":"17","author":"Launois","year":"1998","journal-title":"Int Rev Immunol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1084\/jem.169.1.59","article-title":"Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets","volume":"169","author":"Heinzel","year":"1989","journal-title":"J Exp Med"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.4103\/0022-3859.929","article-title":"Leishmaniasis in HIV infection","volume":"49","author":"Paredes","year":"2003","journal-title":"J Postgrad Med"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB12","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12026-008-8016-2","article-title":"Persistent parasites and immunologic memory in cutaneous leishmaniasis: implications for vaccine designs and vaccination strategies","volume":"41","author":"Okwor","year":"2008","journal-title":"Immunol Res"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01272.x-BIB13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00430-009-0114-9","article-title":"What determines the success or failure of intracellular cutaneous parasites? Lessons learned from leishmaniasis","volume":"198","author":"Maurer","year":"2009","journal-title":"Med Microbiol Immunol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1365-4362.1989.tb04814.x","article-title":"Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement","volume":"28","author":"al-Gindan","year":"1989","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB15","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4269\/ajtmh.1995.53.380","article-title":"Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil","volume":"53","author":"Sousa Ade","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01272.x-BIB16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/0738-081X(96)00058-2","article-title":"Cutaneous leishmaniasis: clinical aspect","volume":"14","author":"Dowlati","year":"1996","journal-title":"Clin Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01272.x-BIB17","doi-asserted-by":"crossref","first-page":"E69","DOI":"10.1086\/340526","article-title":"Failure of early treatment of cutaneous leishmaniasis in preventing the development of an ulcer","volume":"34","author":"Machado","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.idc.2004.11.005","article-title":"Cutaneous leishmaniasis in the returning traveler","volume":"19","author":"Magill","year":"2005","journal-title":"Infect Dis Clin North Am"},{"issue":"11","key":"10.1111\/j.1529-8019.2009.01272.x-BIB19","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1086\/425747","article-title":"Old world leishmaniasis: an emerging infection among deployed US military and civilian workers","volume":"39","author":"Weina","year":"2004","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1111\/j.1529-8019.2009.01272.x-BIB20","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/429238","article-title":"Randomized, double-blind clinical trial of topical imiquimod 5% with parenteral meglumine antimoniate in the treatment of cutaneous leishmaniasis in Peru","volume":"40","author":"Miranda-Verastegui","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4269\/ajtmh.1995.53.162","article-title":"A randomized, placebo-controlled trial in Tunisia treating cutaneous leishmaniasis with paromomycin ointment","volume":"53","author":"Ben Salah","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB22","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4269\/ajtmh.1995.53.648","article-title":"A randomized, placebo-controlled trial of a two-week regimen of aminosidine (paromomycin) ointment for treatment of cutaneous leishmaniasis in Iran","volume":"53","author":"Asilian","year":"1995","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01272.x-BIB23","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa011882","article-title":"Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major","volume":"346","author":"Alrajhi","year":"2002","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB24","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-4632.2008.03417.x","article-title":"Treatment of New World cutaneous leishmaniasis - a systematic review with a meta-analysis","volume":"47","author":"Tuon","year":"2008","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01272.x-BIB25","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1021\/jm900185q","article-title":"Molecular basis of antimony treatment in leishmaniasis","volume":"52","author":"Baiocco","year":"2009","journal-title":"J Med Chem"},{"key":"10.1111\/j.1529-8019.2009.01272.x-BIB26","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1099\/jmm.0.46841-0","article-title":"Molecular mechanisms of antimony resistance in Leishmania","volume":"56","author":"Ashutosh","year":"2007","journal-title":"J Med Microbiol"},{"key":"10.1111\/j.1529-8019.2009.01272.x-BIB27","volume-title":"Drugs for parasitic infections","author":"The Medical Letter Inc","year":"2008"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1023\/A:1016251023427","article-title":"Pharmacokinetics of antimony in patients treated with sodium stibogluconate for cutaneous leishmaniasis","volume":"12","author":"Jaser","year":"1995","journal-title":"Pharm Res"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB29","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1590\/S0037-86822006000200001","article-title":"Factors associated with treatment failure of cutaneous leishmaniasis with meglumine antimoniate","volume":"39","author":"Rodrigues","year":"2006","journal-title":"Rev Soc Bras Med Trop"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01272.x-BIB30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.4269\/ajtmh.2004.71.577","article-title":"Comparison of generic to branded pentavalent antimony for treatment of new world cutaneous leishmaniasis","volume":"71","author":"Soto","year":"2004","journal-title":"Am J Trop Med Hyg"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01272.x-BIB31","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1179\/136485906X118495","article-title":"Generic sodium stibogluconate is as safe and effective as branded meglumine antimoniate, for the treatment of tegumentary leishmaniasis in Isiboro Secure Park, Bolivia","volume":"100","author":"Bermudez","year":"2006","journal-title":"Ann Trop Med Parasitol"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB32","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1590\/S0037-86822000000600004","article-title":"Comparative assessment of the efficacy and toxicity of N-methyl-glucamine and BP88 sodium stibogluconate in the treatment of localized cutaneous leishmaniasis","volume":"33","author":"Deps","year":"2000","journal-title":"Rev Soc Bras Med Trop"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1590\/S0037-86822000000400009","article-title":"Comparative study between sodium stibogluconate BP 88 and meglumine antimoniate in cutaneous leishmaniasis treatment. II. Biochemical and cardiac toxicity","volume":"33","author":"Saldanha","year":"2000","journal-title":"Rev Soc Bras Med Trop"},{"issue":"11","key":"10.1111\/j.1529-8019.2009.01272.x-BIB34","doi-asserted-by":"crossref","first-page":"916","DOI":"10.47102\/annals-acadmedsg.V37N11p916","article-title":"Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime","volume":"37","author":"Sadeghian","year":"2008","journal-title":"Ann Acad Med Singapore"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB35","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaad.2006.06.044","article-title":"Liposomal amphotericin B in comparison to sodium stibogluconate for cutaneous infection due to Leishmania braziliensis","volume":"56","author":"Solomon","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.4269\/ajtmh.1985.34.702","article-title":"Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)","volume":"34","author":"Chulay","year":"1985","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB37","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.clindermatol.2006.05.008","article-title":"Cutaneous leishmaniasis","volume":"25","author":"Bailey","year":"2007","journal-title":"Clin Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB38","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaad.2007.01.016","article-title":"Treatment of acute Old World cutaneous leishmaniasis: a systematic review of the randomized controlled trials","volume":"57","author":"Khatami","year":"2007","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"10.1111\/j.1529-8019.2009.01272.x-BIB39","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1468-3083.2009.03157.x","article-title":"Treatment of cutaneous leishmaniasis with intralesional sodium stibogluconate","volume":"23","author":"Solomon","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"11","key":"10.1111\/j.1529-8019.2009.01272.x-BIB40","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-4362.2002.01633.x","article-title":"Pentamidine, the drug of choice for the treatment of cutaneous leishmaniasis in Surinam","volume":"41","author":"Lai","year":"2002","journal-title":"Int J Dermatol"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01272.x-BIB41","first-page":"492","article-title":"Treatment of mucocutaneous leishmaniasis with pentamidine isothionate","volume":"125","author":"Amato","year":"1998","journal-title":"Ann Dermatol Venereol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2174\/138955706775475993","article-title":"Development of miltefosine for the leishmaniases","volume":"6","author":"Berman","year":"2006","journal-title":"Mini Rev Med Chem"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB43","doi-asserted-by":"crossref","first-page":"210","DOI":"10.4269\/ajtmh.2008.78.210","article-title":"Efficacy of miltefosine for Bolivian cutaneous leishmaniasis","volume":"78","author":"Soto","year":"2008","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB44","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/j.trstmh.2006.02.022","article-title":"Treatment of New World cutaneous leishmaniasis with miltefosine","volume":"100","author":"Soto","year":"2006","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01272.x-BIB45","first-page":"132","article-title":"Miltefosine in cutaneous leishmaniasis","volume":"17","author":"Rahman","year":"2007","journal-title":"J Coll Physicians Surg Pak"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01272.x-BIB46","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1086\/322689","article-title":"Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent","volume":"33","author":"Soto","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01272.x-BIB47","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00436-007-0638-0","article-title":"Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs","volume":"101","author":"Hadighi","year":"2007","journal-title":"Parasitol Res"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000381","article-title":"Is paromomycin an effective and safe treatment against cutaneous leishmaniasis? A meta-analysis of 14 randomized controlled trials","volume":"3","author":"Kim","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB49","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1179\/136485905X514127","article-title":"Efficacy of liposomal amphotericin B (AmBisome) in the treatment of persistent post-kala-azar dermal leishmaniasis (PKDL)","volume":"99","author":"Musa","year":"2005","journal-title":"Ann Trop Med Parasitol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB50","doi-asserted-by":"crossref","first-page":"172","DOI":"10.4269\/ajtmh.2009.80.172","article-title":"Efficacy of cryotherapy versus intralesional meglumine antimoniate (glucantime) for treatment of cutaneous leishmaniasis in children","volume":"80","author":"Layegh","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"9","key":"10.1111\/j.1529-8019.2009.01272.x-BIB51","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1365-4632.2006.02822.x","article-title":"Comparison of intralesional meglumine antimoniate, cryotherapy and their combination in the treatment of cutaneous leishmaniasis","volume":"45","author":"Salmanpour","year":"2006","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01272.x-BIB52","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1086\/518172","article-title":"Role of imiquimod and parenteral meglumine antimoniate in the initial treatment of cutaneous leishmaniasis","volume":"44","author":"Arevalo","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01272.x-BIB53","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1468-3083.2008.02805.x","article-title":"A review of photodynamic therapy in cutaneous leishmaniasis","volume":"22","author":"van der Snoek","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB54","first-page":"40","article-title":"Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol","volume":"13","author":"Momeni","year":"2003","journal-title":"Eur J Dermatol"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01272.x-BIB55","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1046\/j.1365-4362.2002.01527.x","article-title":"Treatment of cutaneous leishmaniasis with a combination of allopurinol and low-dose meglumine antimoniate","volume":"41","author":"Momeni","year":"2002","journal-title":"Int J Dermatol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB56","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4103\/0378-6323.33651","article-title":"Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: results of a pilot study","volume":"73","author":"Negi","year":"2007","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB57","first-page":"287","article-title":"A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis","volume":"45","author":"Nilforoushzadeh","year":"2008","journal-title":"J Vector Borne Dis"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01272.x-BIB58","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1086\/428736","article-title":"Efficacy of thermotherapy to treat cutaneous leishmaniasis caused by Leishmania tropica in Kabul, Afghanistan: a randomized, controlled trial","volume":"40","author":"Reithinger","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01272.x-BIB59","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/j.1365-4632.2008.03804.x","article-title":"Diffuse cutaneous leishmaniasis associated with the immune reconstitution inflammatory syndrome","volume":"47","author":"Sinha","year":"2008","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB60","first-page":"13","article-title":"Cutaneous and mucocutaneous leishmaniasis","volume":"57","author":"Samady","year":"1996","journal-title":"Cutis"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB61","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/0035-9203(69)90116-3","article-title":"Diffuse cutaneous leishmaniasis in Ethiopia. I. The clinical and histological features of the disease","volume":"63","author":"Bryceson","year":"1969","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/0035-9203(93)90030-T","article-title":"The clinical and immunological spectrum of American cutaneous leishmaniasis","volume":"87","author":"Convit","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1111\/j.1529-8019.2009.01272.x-BIB63","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/archderm.1965.01600110025007","article-title":"Disseminated cutaneous leishmaniasis; innoculation to laboratory animals, electron microscopy and fluorescent antibodies studies","volume":"91","author":"Convit","year":"1965","journal-title":"Arch Dermatol"},{"issue":"7","key":"10.1111\/j.1529-8019.2009.01272.x-BIB64","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM198202183060702","article-title":"Specific inhibition of lymphocyte-proliferation responses by adherent suppressor cells in diffuse cutaneous leishmaniasis","volume":"306","author":"Petersen","year":"1982","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB65","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/archderm.1957.01550200057012","article-title":"Disseminated anergic American leishmaniasis; report of three cases of a type clinically resembling lepromatous leprosy","volume":"76","author":"Convit","year":"1957","journal-title":"AMA Arch Derm"},{"issue":"8","key":"10.1111\/j.1529-8019.2009.01272.x-BIB66","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/j.1365-4362.1996.tb03655.x","article-title":"Disseminated American cutaneous leishmaniasis","volume":"35","author":"Bonfante-Garrido","year":"1996","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0733-8635(18)30200-6","article-title":"Laboratory tests for the diagnosis and evaluation of leishmaniasis","volume":"12","author":"Kalter","year":"1994","journal-title":"Dermatol Clin"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01272.x-BIB68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1001\/archderm.1968.01610090073011","article-title":"Disseminated anergic cutaneous leishmaniasis. An autochthonous case in Texas and the Mexican states of Tamaulipas and Nuevo Leon","volume":"97","author":"Simpson","year":"1968","journal-title":"Arch Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB69","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0190-9622(99)70093-9","article-title":"Cutaneous New World leishmaniasis-sporotrichosis coinfection: report of 3 cases","volume":"40","author":"Agudelo","year":"1999","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB70","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0190-9622(96)80121-6","article-title":"Leishmaniasis","volume":"34","author":"Grevelink","year":"1996","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01272.x-BIB71","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0738-081X(99)00047-4","article-title":"Cutaneous leishmaniasis: clinical features and diagnosis","volume":"17","author":"Salman","year":"1999","journal-title":"Clin Dermatol"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB72","doi-asserted-by":"crossref","first-page":"641","DOI":"10.4103\/0378-6323.45111","article-title":"Diffuse cutaneous leishmaniasis: co-infection with human immunodeficiency virus (HIV)","volume":"74","author":"Chaudhary","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB73","first-page":"13","article-title":"Miltefosine for disseminated cutaneous leishmaniasis","volume":"26","author":"Gonzalez","year":"2006","journal-title":"Biomedica"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01272.x-BIB74","doi-asserted-by":"crossref","first-page":"e120","DOI":"10.1086\/430444","article-title":"Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1","volume":"40","author":"Schraner","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB75","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/jac\/dkh058","article-title":"Treatment of cutaneous leishmaniasis among travellers","volume":"53","author":"Blum","year":"2004","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01272.x-BIB76","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/0738-081X(96)00036-3","article-title":"Natural history, clinical evolution, and the host-parasite interaction in New World cutaneous leishmaniasis","volume":"14","author":"Weigle","year":"1996","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB77","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.trstmh.2003.08.001","article-title":"Risk factors for mucosal manifestation of American cutaneous leishmaniasis","volume":"99","author":"Machado-Coelho","year":"2005","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5694\/j.1326-5377.2007.tb00910.x","article-title":"An Australian case of New World cutaneous leishmaniasis","volume":"186","author":"Konecny","year":"2007","journal-title":"Med J Aust"},{"issue":"7470","key":"10.1111\/j.1529-8019.2009.01272.x-BIB79","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bmj.329.7470.842","article-title":"Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America","volume":"329","author":"Ahluwalia","year":"2004","journal-title":"BMJ"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB80","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1067\/S0190-9622(03)01576-7","article-title":"Experience with New World cutaneous leishmaniasis in travelers","volume":"49","author":"Scope","year":"2003","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1111\/j.1529-8019.2009.01272.x-BIB81","doi-asserted-by":"crossref","first-page":"934","DOI":"10.7326\/0003-4819-113-12-934","article-title":"Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis","volume":"113","author":"Franke","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2009.01272.x-BIB82","first-page":"1213","volume-title":"Manson's tropical diseases, 20th ed","author":"Bryceson","year":"1996"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB83","doi-asserted-by":"crossref","first-page":"266","DOI":"10.4269\/ajtmh.2007.77.266","article-title":"Treatment of mucosal leishmaniasis in Latin America: systematic review","volume":"77","author":"Amato","year":"2007","journal-title":"Am J Trop Med Hyg"},{"issue":"4","key":"10.1111\/j.1529-8019.2009.01272.x-BIB84","doi-asserted-by":"crossref","first-page":"394","DOI":"10.4269\/ajtmh.1991.44.394","article-title":"Efficacy and toxicity of pentostam against Panamanian mucosal leishmaniasis","volume":"44","author":"Saenz","year":"1991","journal-title":"Am J Trop Med Hyg"},{"issue":"5","key":"10.1111\/j.1529-8019.2009.01272.x-BIB85","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1590\/S0037-86821996000500011","article-title":"Treatment of American cutaneous leishmaniasis, with lesions in the mucosa, using pentamidine isethionate","volume":"29","author":"Amato","year":"1996","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB86","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0035-9203(97)90404-1","article-title":"Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome","volume":"91","author":"Nonata","year":"1997","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB87","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1590\/S0037-86821997000200007","article-title":"Treatment of the mucosal form of leishmaniasis without response to glucantime, with liposomal amphotericin B","volume":"30","author":"Sampaio","year":"1997","journal-title":"Rev Soc Bras Med Trop"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1590\/S0036-46652000000600004","article-title":"Mucosal leishmaniasis (\u201cespundia\u201d) responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro","volume":"42","author":"Oliveira-Neto","year":"2000","journal-title":"Brazil. Rev Inst Med Trop Sao Paulo"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB89","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1086\/510494","article-title":"Treatment of mucosal leishmaniasis with a lipid formulation of amphotericin B","volume":"44","author":"Amato","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1111\/j.1529-8019.2009.01272.x-BIB90","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1288\/00005537-198909000-00006","article-title":"Mucosal leishmaniasis in Brazil","volume":"99","author":"Zajtchuk","year":"1989","journal-title":"Laryngoscope"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01272.x-BIB91","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clim.2008.05.007","article-title":"Local immunological factors associated with recurrence of mucosal leishmaniasis","volume":"128","author":"Tuon","year":"2008","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01272.x-BIB92","first-page":"295","article-title":"Challenges in the diagnosis of post kala-azar dermal leishmaniasis","volume":"123","author":"Salotra","year":"2006","journal-title":"Indian J Med Res"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB93","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1365-4362.1995.tb03584.x","article-title":"Post-kala-azar dermal leishmaniasis","volume":"34","author":"Ramesh","year":"1995","journal-title":"Int J Dermatol"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB94","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/S0035-9203(01)90219-6","article-title":"Leishmaniasis in Sudan. Post kala-azar dermal leishmaniasis","volume":"95","author":"Zijlstra","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB95","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1177\/095646249500600214","article-title":"Disseminated cutaneous leishmaniasis in an HIV-infected patient","volume":"6","author":"Herrera","year":"1995","journal-title":"Int J STD AIDS"},{"issue":"1","key":"10.1111\/j.1529-8019.2009.01272.x-BIB96","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1440-0960.2007.00323.x","article-title":"Diffuse cutaneous leishmaniasis in an HIV-positive patient in western Africa","volume":"48","author":"Niamba","year":"2007","journal-title":"Australas J Dermatol"},{"issue":"3","key":"10.1111\/j.1529-8019.2009.01272.x-BIB97","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1111\/j.1529-8019.2009.01272.x-BIB98","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1086\/515027","article-title":"Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience","volume":"27","author":"Aronson","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1111\/j.1529-8019.2009.01272.x-BIB99","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4269\/ajtmh.2005.72.133","article-title":"Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis","volume":"72","author":"Andersen","year":"2005","journal-title":"Am J Trop Med Hyg"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2009.01272.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2009.01272.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T11:39:50Z","timestamp":1685187590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2009.01272.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":99,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2009,11]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2009.01272.x","relation":{},"ISSN":["1396-0296","1529-8019"],"issn-type":[{"value":"1396-0296","type":"print"},{"value":"1529-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}